12/28/2017 · Looking for insights on Brainstorm-cell-therapeutics (NASDAQ:BCLI) stock? View BCLI's stock ratings, price targets, earnings, commentary and news at Find the latest Aberdeen Standard Bloomberg All (BCI) stock quote, history, news and other vital information to help you with your stock trading and investing. ValuEngine cut shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI) from a buy rating to a hold rating in a research note released on Wednesday, ValuEngine reports. Separately, Maxim Group restated a buy rating and set a $9.00 price target on shares of Brainstorm Cell Therapeutics in a research note on Tuesday, May 14th. Shares of BCLI […]

11/4/2019 · The following is a detailed excerpt of an interview conducted over email with the CEO of Brainstorm Cell Therapeutics, Chaim Lebovits.This interview follows from an article we wrote about BCLI in May. 12/28/2017 · Looking for insights on Brainstorm-cell-therapeutics (NASDAQ:BCLI) stock? View BCLI's stock ratings, price targets, earnings, commentary and news at Find the latest Aberdeen Standard Bloomberg All (BCI) stock quote, history, news and other vital information to help you with your stock trading and investing. ValuEngine cut shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI) from a buy rating to a hold rating in a research note released on Wednesday, ValuEngine reports. Separately, Maxim Group restated a buy rating and set a $9.00 price target on shares of Brainstorm Cell Therapeutics in a research note on Tuesday, May 14th. Shares of BCLI […] Summary quote, performance, and fundamental analysis for NASDAQ:BCLI Brainstorm Cell Therapeutics Inc. Summary quote, performance, and fundamental analysis for NASDAQ:BCLI Brainstorm Cell Therapeutics Inc. Real time Brainstorm Cell Therapeutics (BCLI) Interactive Chart. Rule Breakers High-growth stocks. 175%. 83%. Returns as of 12/23/2019. View all Motley Fool Services.

Find the latest Institutional Holdings data for Brainstorm Cell Therapeutics Inc.

View today's stock price, news and analysis for Brainstorm Cell Therapeutics Inc. (BCLI). Barron's also provides Cell Therapeutics Inc. BCLIU.S.: Nasdaq  14 Nov 2019 NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI),. Common stock of $0.00005 par value - Authorized: 100,000,000  See Brainstorm Cell Therapeutics price target based on 1 analysts offering 12 month price targets for Brainstorm Cell Therapeutics in the last 3 months. Common Stock Shares Outstanding, 22,606,492 shares (as of 2019-09-30) BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI) has 48 institutional investors  Brainstorm Cell stocks price quote with latest real-time prices, charts, Brainstorm Cell (BCLI). Brainstorm Cell (BCLI). 4.28 -0.01 (-0.23%) 12/31/19 [NASDAQ].

Researching Brainstorm Cell Therapeutics (NASDAQ:BCLI) stock? View BCLI's stock price, price target, earnings, financials, forecast, insider trades, news, and 

Get the latest Brainstorm Cell Therapeutics In (BCLI) stock news and headlines to By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH  View live BRAINSTROM CELL THERAPEUTICS chart to track its stock's price action. Find market predictions, BCLI financials and market news. Researching Brainstorm Cell Therapeutics (NASDAQ:BCLI) stock? View BCLI's stock price, price target, earnings, financials, forecast, insider trades, news, and  BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI) is a clinical-stage, publicly-traded biotechnology company focused on the development of best-in-class 

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours 

Brainstorm Cell Therapeutics Inc. BCLI 4.20 0.14 (3.53%). NASDAQUpdated Dec 28, 2019 12:23 AM. 2,677. Watchers. Watch. Filter by: Real-Time. 0 New Post. Stock analysis for BrainStorm Cell Therapeutics Inc (BCLI:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and  Get the latest Brainstorm Cell Therapeutics In (BCLI) stock news and headlines to By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH  View live BRAINSTROM CELL THERAPEUTICS chart to track its stock's price action. Find market predictions, BCLI financials and market news. Researching Brainstorm Cell Therapeutics (NASDAQ:BCLI) stock? View BCLI's stock price, price target, earnings, financials, forecast, insider trades, news, and  BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI) is a clinical-stage, publicly-traded biotechnology company focused on the development of best-in-class  BrainStorm (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating Stock Quote. NASDAQ 

NASDAQ:BCLI BCLI is a flag from a previous uptrend. Its earnings report is the 23rd and that could be a potential bullish or bearish catalyst. Potential buy signals are if Price Oscillator sees support at its moving average, MACD positively crosses over, Parabolic SAR gives a buy signal.

Get breaking news and analysis on Brainstorm Cell Therapeutics Inc. (BCLI) stock, price quote and chart, trading and NASDAQ |At close:4:00 PM 12/31/19. Israel had more companies listed in 2012 on the NASDAQ stock exchange than any country Brainstorm Cell Therapeutics Inc, BCLI, 2004, Biotech. As of 10:03 AM PST May 01 on the NASDAQ ∙ Minimum 15 minute delay Resale By Selling Securityholders Of Up To 842,000 Shares Of Co's Common Stock. View today's stock price, news and analysis for Brainstorm Cell Therapeutics Inc. (BCLI). Barron's also provides Cell Therapeutics Inc. BCLIU.S.: Nasdaq  14 Nov 2019 NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI),. Common stock of $0.00005 par value - Authorized: 100,000,000 

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours  Find the latest analyst research for Brainstorm Cell Therapeutics Inc. Common  Find the latest Insider Activity data for Brainstorm Cell Therapeutics Inc.